Endothelin-1, nitric oxide, serotonin and high blood pressure in male adolescents

References

• National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and AdolescentsThe fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescentsPediatrics20041142 Suppl 4th Report55557615286277
   PubMed Web of Science ®Google Scholar
• DobsonCPEideMNylundCMHypertension Prevalence, Cardiac Complications, and Antihypertensive Medication Use in ChildrenJ Pediatr20151671929725957976
   PubMed Web of Science ®Google Scholar
• FalknerBHypertension in children and adolescents: epidemiology and natural historyPediatr Nephrol20102571219122419421783
   PubMed Web of Science ®Google Scholar
• AnyaegbuEIDharnidharkaVRHypertension in the teenagerPediatr Clin North Am201461113115124267462
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRNational Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 ReportJAMA20032892560257212748199
   PubMed Web of Science ®Google Scholar
• TaddeiSVirdisAGhiadoniLVersariDEndotheliumSAAging, and hypertensionCurr Hypertens Rep200681848916600164
   PubMed Web of Science ®Google Scholar
• EndemannDHSchiffrinELEndothelial dysfunctionJ Am Soc Nephrol20041581983199215284284
   PubMed Web of Science ®Google Scholar
• AkcaboyMKulaSGöktasTEffect of plasma NOx values on cardiac function in obese hypertensive and normotensive pediatric patientsPediatr Nephrol201631347348326482254
   PubMed Web of Science ®Google Scholar
• BöhmFPernowJThe importance of endothelin-1 for vascular dysfunction in cardiovascular diseaseCardiovasc Res200776181817617392
   PubMed Web of Science ®Google Scholar
• MazzucaMQKhalilRAVascular endothelin receptor type B: structure, function and dysregulation in vascular diseaseBiochem Pharmacol201284214716222484314
   PubMed Web of Science ®Google Scholar
• MachidaTIizukaKHirafujiM5-hydroxytryptamine and its receptors in systemic vascular wallsBiol Pharm Bull20133691416141923995652
   PubMed Web of Science ®Google Scholar
• BhaskaranSZaluskiJBanes-BerceliAMolecular interactions of serotonin (5-HT) and endothelin-1 in vascular smooth muscle cells: in vitro and ex vivo analysesAm J Physiol Cell Physiol20143062143151
   Web of Science ®Google Scholar
• MercadoCPKilicFMolecular mechanisms of SERT in platelets: regulation of plasma serotonin levelsMol Interv201010423124120729489
   PubMedGoogle Scholar
• GamohSHisaHYamamotoR5-hydroxytryptamine receptors as targets for drug therapies of vascular-related diseasesBiol Pharm Bull20133691410141523995651
   PubMed Web of Science ®Google Scholar
• CallebertJEsteveJMHervéPEvidence for a control of plasma serotonin levels by 5-hydroxytryptamine(2B) receptors in miceJ Pharmacol Exp Ther2006317272473116461587
   PubMed Web of Science ®Google Scholar
• World Medical AssociationWMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human SubjectsWorld Medical Association Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Published March 2018Accessed May 22, 2018
   Google Scholar
• Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publicationJ Pharmacol Pharmacother201011425821808590
   PubMedGoogle Scholar
• Institute of Social and Preventive Medicine (ISPM)STROBE StatementISPM – University of Bern Available from: https://strobe-statement.org/index.php?id=available-checklists. Published November 2007Accessed May 23, 2018
   Google Scholar
• PalatiniPFrigoGBertoloORomanEDa CortàRWinnickiMValidation of the A&D TM-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects’ characteristicsBlood Press Monit19983425526010212363
   PubMedGoogle Scholar
• YipGWSoHKLiAMTomlinsonBWongSNSungRYValidation of A&D TM-2430 upper-arm blood pressure monitor for ambulatory blood pressure monitoring in children and adolescents, according to the British Hypertension Society protocolBlood Press Monit2012172767922391521
   PubMed Web of Science ®Google Scholar
• UrbinaEAlpertBFlynnJAmbulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure researchHypertension200852343345118678786
   PubMed Web of Science ®Google Scholar
• Cheikh IsmailLKnightHEOhumaEOHochLChumleaWCInternational Fetal and Newborn Growth Consortium for the 21st Century. Anthropometric standardisation and quality control protocols for the construction of new, international, fetal and newborn growth standards: the INTERGROWTH-21st ProjectBJOG2013120Suppl 2485523841854
   PubMedGoogle Scholar
• GłowińskaBUrbanMHryniewiczAPeczyńskaJFlorysBAl-HwishMEndothelin-1 plasma concentration in children and adolescents with atherogenic risk factorsKardiol Pol2004611032933815841114
   PubMedGoogle Scholar
• KatonaESettakisGVargaZTarget-organ damage in adolescent hypertension. Analysis of potential influencing factors, especially nitric oxide and endothelin-1J Neurol Sci20062472138143 Available from: https://www.ncbi.nlm.nih.gov/pubmed/16737713Accessed May 21, 201816737713
   PubMed Web of Science ®Google Scholar
• SchneiderJGTillyNHierlTElevated plasma endothelin-1 levels in diabetes mellitusAm J Hypertens2002151196797212441216
   PubMed Web of Science ®Google Scholar
• GodoSShimokawaHDivergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasisFree Radic Biol Med201710941027988339
   PubMed Web of Science ®Google Scholar
• VanhouttePMShimokawaHFeletouMTangEHEndothelial dysfunction and vascular disease - a 30th anniversary updateActa Physiol201721912296
   PubMed Web of Science ®Google Scholar
• GkaliagkousiEFerroANitric oxide signalling in the regulation of cardiovascular and platelet functionFront Biosci2011161618731897
   Google Scholar
• ZhangCHeinTWWangWUpregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arteriolesHypertension2004446935943 Available from: https://www.ncbi.nlm.nih.gov/pubmed/15492130Accessed May 22, 201815492130
   PubMed Web of Science ®Google Scholar
• FortePCoplandMSmithLMMilneESutherlandJBenjaminNBasal nitric oxide synthesis in essential hypertensionLancet199734990558378429121259
   PubMed Web of Science ®Google Scholar
• Oliveira-PaulaGHLacchiniRTanus-SantosJEInducible nitric oxide synthase as a possible target in hypertensionCurr Drug Targets201415216417424102471
   PubMed Web of Science ®Google Scholar
• CamillettiAMorettiNGiacchettiGDecreased nitric oxide levels and increased calcium content in platelets of hypertensive patientsAm J Hypertens2001144 Pt 138238611336186
   PubMed Web of Science ®Google Scholar
• WattsSW5-HT in systemic hypertension: foefriend or fantasy? Clin Sci2005108539941215831089
   PubMed Web of Science ®Google Scholar
• FetkovskaNPletscherAFerracinFAmsteinRBuhlerFRImpaired uptake of 5 hydroxytryptamine platelet in essential hypertension: clinical relevanceCardiovasc Drugs Ther19904Suppl 11051591704794
   PubMedGoogle Scholar
• NiWWattsSW5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERTClin Exp Pharmacol Physiol200633757558316789923
   PubMed Web of Science ®Google Scholar
• KamalLALe Quan-BuiKHMeyerPDecreased uptake of 3H-serotonin and endogenous content of serotonin in blood platelets in hypertensive patientsHypertension198465685736746086
   PubMed Web of Science ®Google Scholar
• NityanandSTekwaniBLChandraMShankerKSinghBNKinetics of serotonin in platelets in essential hypertensionLife Sci19904653673721689448
   PubMed Web of Science ®Google Scholar
• IsbisterGKBoweSJDawsonAWhyteIMRelative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdoseJ Toxicol Clin Toxicol200442327728515362595
   PubMed Web of Science ®Google Scholar
• NiWThompsonJMNorthcottCALookinglandKWattsSWThe serotonin transporter is present and functional in peripheral arterial smooth muscleJ Cardiovasc Pharmacol2004436770807115167270
   PubMed Web of Science ®Google Scholar
• NiWWattsSW5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERTClin Exp Pharmacol Physiol200633757558316789923
   PubMed Web of Science ®Google Scholar
• HaszonIPappFKovácsJPlatelet aggregation, blood viscosity and serum lipids in hypertensive and obese childrenEur J Pediatr2003162638539012684895
   PubMed Web of Science ®Google Scholar